Coincidentally, data from mouse models confirm that when fed a high-fat diet, mice lacking CCR2 eat less and are less likely to become obese, and CCR2 antagonist therapy lowers inflammatory aspects of obesity, such as macrophage infiltration in adipose tissue (92). This evidence concerns the gene CCR2 and obesity disorder.